We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The investigational injection SI-6603 may decrease pain ...
PLYMOUTH, Minn.--(BUSINESS WIRE)--SpineThera, Inc., a leading clinical-stage pharmaceutical company specializing in innovative injectable drugs, is thrilled to announce groundbreaking results from an ...
May 27, 2010 — The tumor necrosis factor (TNF)–α inhibitor adalimumab may be helpful as adjunct treatment of sciatica, according to the results of a multicenter, randomized, double-blind, ...
PARSIPPANY, N.J.--(BUSINESS WIRE)--Ferring Pharmaceuticals and its clinical development partner, Seikagaku Corporation (Seikagaku), today announced they will be presenting an analysis of data at the ...
The U.S. FDA’s Anesthetic and Analgesic Drug Products Advisory Committee will scrutinize Jan. 10 the safety and efficacy of Ferring Pharmaceuticals Inc.’s SI-6603 (condoliase), a chemonucleolytic drug ...
Please provide your email address to receive an email when new articles are posted on . Intradiscal oxygen-ozone chemonucleolysis met non-inferiority criteria and achieved similar rapid, significant ...
PALO ALTO, Calif., June 14, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results